Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
AAN 2018New AAN Guidelines Advocate Early MS TreatmentNew guidelines update guidance on starting, switching, and stopping disease-modifying therapies in multiple sclerosis and recommend an earlier, rather than later, start to treatment.
Medscape Medical News, April 23, 2018
AAN 2018ACHIEVE I: Ubrogepant Meets Endpoints for Acute Migraine Phase 3 trial results show that two doses of oral ubrogepant, a novel CGRP-targeting medication, met the primary endpoints of decreasing acute migraine pain and symptoms compared with placebo.
Germany's Merck Seeks Partners for Cancer and Immune System DrugsMerck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing deals to help fund clinical trials, according to its head of drug R&D.
